Author pages are created from data sourced from our academic publisher partnerships and public sources.
Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy.
The removal of beta(1)-adrenergic receptor (beta(1)AR) autoantibodies by immunoadsorption (IA) has been proposed as a potential mechanism for the improvement of the left ventricular function in… Expand
New insights into the pathogenesis of dilated cardiomyopathy: possible underlying autoimmune mechanisms and therapy.
In the present study, autoimmune processes involved in the pathogenesis of dilated cardiomyopathy (DCM) are discussed. Genetic predisposition, persistent viral infection, and molecular mimicry have… Expand
Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
OBJECTIVE Our objective was to evaluate the influence of polymorphisms at codons 49 and 389 of the beta1-adrenergic receptor (beta1-AR) on the response to beta-blockers and outcome in patients with… Expand
Hyperinsulinemia: effect on cardiac mass/function, angiotensin II receptor expression, and insulin signaling pathways.
- A. Samuelsson, E. Bollano, +5 authors A. Holmäng
- Biology, Medicine
- American journal of physiology. Heart and…
- 24 March 2006
To investigate the association between hyperinsulinemia and cardiac hypertrophy, we treated rats with insulin for 7 wk and assessed effects on myocardial growth, vascularization, and fibrosis in… Expand
Growth Hormone Improves Bioenergetics and Decreases Catecholamines in Postinfarct Rat Hearts* *The study was supported by grants from the Swedish Heart and Lung Foundation, the Swedish Medical…
The aims of this study were to examine, in vivo, the effects of GH treatment on myocardial energy metabolism, function, morphology, and neurohormonal status in rats during the early postinfarct… Expand
Beta1-adrenoceptor antibodies induce apoptosis in adult isolated cardiomyocytes.
- Y. Staudt, R. Mobini, M. Fu, S. Felix, J. Kühn, A. Staudt
- Chemistry, Medicine
- European journal of pharmacology
- 11 April 2003
beta(1)-Adrenoceptor autoantibodies are present in about 30% of patients suffering from dilated cardiomyopathy. The apoptotic effects mediated by beta(1)-adrenoceptor antibodies remain to be studied.… Expand
Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial
- R. Mobini, V. Tremaroli, +8 authors Per-Anders Jansson
- Diabetes, obesity & metabolism
- 1 April 2017
To investigate the metabolic effects of 12‐week oral supplementation with Lactobacillus reuteri DSM 17938 in patients with type 2 diabetes on insulin therapy.
A monoclonal antibody directed against an autoimmune epitope on the human beta1-adrenergic receptor recognized in idiopathic dilated cardiomyopathy.
- R. Mobini, M. Fu, G. Wallukat, Y. Magnusson, A. Hjalmarson, J. Hoebeke
- Medicine, Biology
- 1 April 2000
A monoclonal antibody (MAb M16) was obtained by immunizing Balb/C mice with free peptide H26R, corresponding to the second extracellular loop of the human beta1-adrenergic receptor (beta1AR), against… Expand
Probing the immunological properties of the extracellular domains of the human beta(1)-adrenoceptor.
- R. Mobini, Y. Magnusson, G. Wallukat, M. Viguier, A. Hjalmarson, J. Hoebeke
- Biology, Medicine
- Journal of autoimmunity
- 1 September 1999
The human beta(1)-adrenoceptor is an immune target for autoantibodies with functional activity in cardiovascular diseases. Different epitopes on the extracellular domains of the receptor are… Expand
The effects of hypoxia and hypercapnia on renal and heart function, haemodynamics and plasma hormone levels in stable COPD patients *
Background: Fluid retention with oedema is an important clinical problem in advanced chronic obstructive pulmonary disease (COPD).